Full text
PDF














Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADLERSBERG D., SCHAEFER L., DRACHMAN S. R. Development of hypercholesteremia during cortisone and ACTH therapy. J Am Med Assoc. 1950 Nov 11;144(11):909–914. doi: 10.1001/jama.1950.02920110021006. [DOI] [PubMed] [Google Scholar]
- BOLAND E. W. Recent advances in rheumatic diseases. Calif Med. 1955 Feb;82(2):65–76. [PMC free article] [PubMed] [Google Scholar]
- BUNIM J. J., BLACK R. L., BOLLET A. J., PECHET M. M. Metabolic effects of metacortandralone and metacortandracin. Ann N Y Acad Sci. 1955 May 27;61(2):358–368. doi: 10.1111/j.1749-6632.1955.tb42485.x. [DOI] [PubMed] [Google Scholar]
- BUNIM J. J., PECHET M. M., BOLLET A. J. Studies on metacortandralone and metacortandracin in rheumatoid arthritis; antirheumatic potency, metabolic effects, and hormonal properties. J Am Med Assoc. 1955 Jan 22;157(4):311–318. doi: 10.1001/jama.1955.02950210007003. [DOI] [PubMed] [Google Scholar]
- CLARK W. S., BAUER W., APPLETON J., MANNING E. The relationship of alterations in mineral and nitrogen metabolism to disease activity in a patient with rheumatoid arthritis. Acta Rheumatol Scand. 1956;2(4):193–212. doi: 10.3109/rhe1.1956.2.issue-1-4.21. [DOI] [PubMed] [Google Scholar]
- COHEN A., TURNER R., DUNSMORE R. Prednisone in the treatment of rheumatoid arthritis. N Engl J Med. 1955 Dec 29;253(26):1150–1152. doi: 10.1056/NEJM195512292532604. [DOI] [PubMed] [Google Scholar]
- DORDICK J. R., GLUCK E. J. Preliminary clinical trials with prednisone (meticorten) in rheumatic diseases; comparative antirheumatic potency, metabolic activity, and hormonal properties. J Am Med Assoc. 1955 May 21;158(3):166–170. doi: 10.1001/jama.1955.02960030016005. [DOI] [PubMed] [Google Scholar]
- MARGOLIS H. M., BARR J. H., Jr, STOLZER B. L., EISENBEIS C. H., Jr, MARTZ E. W., Jr Effects of prednisone (meticorten) on manifestations of rheumatoid arthritis; report of early clinical observations. J Am Med Assoc. 1955 Jun 11;158(6):454–458. doi: 10.1001/jama.1955.02960060012004. [DOI] [PubMed] [Google Scholar]
- NELSON C. T. Pemphigus vulgaris treated with metacortandracin; case report. J Invest Dermatol. 1955 Apr;24(4):377–378. doi: 10.1038/jid.1955.52. [DOI] [PubMed] [Google Scholar]
- SALASSA R. M., POWER M. H., ULRICH J. A., HAYLES A. B. Observations on the metabolic effects of vitamin D in Fanconi's syndrome. Proc Staff Meet Mayo Clin. 1954 Apr 21;29(8):214–224. [PubMed] [Google Scholar]
- SPIES T. D., STONE R. E., GARCIA LOPEZ G., DIAZ TELLECHEA C. M., LOPEZ TOCA R., REBOREDO A., SUAREZ R. M., Sr Prednisone and prednisolone as therapeutic agents; progress report on their integration into general medical practice. J Am Med Assoc. 1955 Oct 15;159(7):645–652. doi: 10.1001/jama.1955.02960240011004. [DOI] [PubMed] [Google Scholar]
- THORN G. W., RENOLD A. E., MORSE W. I., GOLDFIEN A., REDDY W. J. Highly potent adrenal cortical steroids: structure and biologic activity. Ann Intern Med. 1955 Nov;43(5):979–1000. doi: 10.7326/0003-4819-43-5-979. [DOI] [PubMed] [Google Scholar]
- VILLA L., BALLABIO C. B., SALA G. Metacortandracin and 9-alpha-fluoro hydrocortisone acetate in rheumatic diseases. Ann Rheum Dis. 1955 Sep;14(3):251–258. doi: 10.1136/ard.14.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WANG C. I., BOSSAK E. T., ADLERSBERG D. Prednisone and plasma lipids. J Clin Endocrinol Metab. 1955 Oct;15(10):1308–1310. doi: 10.1210/jcem-15-10-1308. [DOI] [PubMed] [Google Scholar]
- WARD L. E., POLLEY H. F., SLOCUMB C. H., HENCH P. S. Cortisone in treatment of rheumatoid arthritis. J Am Med Assoc. 1953 May 9;152(2):119–126. doi: 10.1001/jama.1953.03690020011003. [DOI] [PubMed] [Google Scholar]
- WARD L. E., POLLEY H. F., SLOCUMB C. H., HENCH P. S., MASON H. L., MATTOX V. R., POWER M. H. The effects of aldosterone (electrocortin) and of 9alpha-fluorohydrocortisone acetate on rheumatoid arthritis: preliminary report. Proc Staff Meet Mayo Clin. 1954 Dec 22;29(26):649–663. [PubMed] [Google Scholar]
